Serratrin Improves Joint Comfort and Physical Function

Better Walking, Get Up and Go and Reduced Pain Scores

The clinical study  on Serratrin  is currently not published, but we’d like to provide you with more information on the trial. Please fill out the form on this page and we will contact you.

Improvements shown within a week

In a randomized controlled trial, Serratrin was compared to placebo and to another commercially available Boswellia extract in healthy, ambulatory women and men aged 30-65 years. The primary outcome measure was an 80-meter fast-paced walk test. Secondary endpoints included a 30-second chair stand test, VAS, WOMAC A (pain), WOMAC B (stiffness), WOMAC C (physical function), and primary knee flexion range of motion.